CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Schnell Biopharmaceuticals Incorporation Company Snapshot
Schnell Biopharmaceuticals Incorporation operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Schnell Biopharmaceuticals Incorporation with three other companies in this sector in South Korea: Seoul Pharma Co., Ltd. (2016 sales of 45.92 billion Korean Won [US$41.10 million] ), DHP Korea Co Ltd (44.72 billion Korean Won [US$40.02 million] ), and Pharma Reaserch Products Co Ltd (45.95 billion Korean Won [US$41.13 million] ).

Sales Analysis. During the year ended December of 2016, sales at Schnell Biopharmaceuticals Incorporation were 44.12 billion Korean Won (US$39.49 million). This is an increase of 9.4% versus 2015, when the company's sales were 40.32 billion Korean Won. This was the third consecutive year of growth at Schnell Biopharmaceuticals Incorporation.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Schnell Biopharmaceuticals Incorporation
  Stock Performance Chart for Schnell Biopharmaceuticals Incorporation
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 3,265.00
(Figures in Korean Won)
1 Week -5.8%   13 Weeks -11.3%  
4 Weeks -17.6%   52 Weeks -26.0%  
 
Schnell Biopharmaceuticals Incorporation Key Data:
  Ticker: 003060 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 44,122,492,681
(Year Ending Jan 2017).
Employees: 96
  Currency: Korean Won Market Cap: 264,039,198,290
  Fiscal Yr Ends: December Shares Outstanding: 80,869,586
  Share Type: Common Closely Held Shares: 6,262,500
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.